WASHINGTON — Here’s a look at how area members of Congress voted over the week ending Sept. 13.
Along with this week’s roll call votes, the House also passed these measures: the Confirmation Of Congressional Observer Access Act (H.R. 6513), to confirm the requirement that states allow access to designated congressional election observers to observe the election administration procedures in congressional elections; the Subterranean Border Defense Act (H.R. 7404), to require annual reports on counter illicit cross-border tunnel operations; the No Russian Tunnel to Crimea Act (H.R. 7701), to require sanctions on any foreigner who knowingly participates in the construction, maintenance, or repair of a tunnel or bridge that connects the Russian mainland with the Crimean peninsula; and the Economic Espionage Prevention Act (H.R. 8361), to impose sanctions with respect to economic or industrial espionage by foreign adversarial companies.
House
COMPETITION WITH CHINA: The House has passed the Countering the PRC Malign Influence Fund Authorization Act (H.R. 1157), sponsored by Rep. Andy Barr, R-Ky., to authorize $325 million of annual spending, for the next three years, on government actions against China’s attempts at malign influence on the U.S. and its allies. Barr said the bill sought to “direct those scarce taxpayer resources effectively so that they actually do the job that the taxpayers deserve and we actually win this fight” with China. The vote, on Sept. 9, was 351 yeas to 36 nays.
YEAS: Marie Gluesenkamp Perez D-3rd
CONTRACTS WITH CHINESE BIOTECHNOLOGY FIRMS: The House has passed the BIOSECURE Act (H.R. 8333), sponsored by Rep. Brad R. Wenstrup, R-Ohio, to bar federal government agencies from reaching contracts with, or sending grant funds to, any of five different China-based biotechnology companies that have been deemed to be a risk to U.S. national security. Wenstrup said the ban “will help protect the biologic data of American patients and make sure that their data does not fall into the hands of our adversaries.” A bill opponent, Rep. James P. McGovern, D-Mass., cited a lack of due process and transparency for determining which companies to ban, as well as the political nature of the ban. The vote, on Sept. 9, was 306 yeas to 81 nays.